Menu
Log in
Forgot password
Log in
Forgot password

News

  • Home
  • Resources
  • Literature Updates
  • Second primary malignancies in patients with clinical T1bN0 esophageal squamous cell carcinoma after definitive therapies: supplementary analysis of the JCOG trial: JCOG0502

Second primary malignancies in patients with clinical T1bN0 esophageal squamous cell carcinoma after definitive therapies: supplementary analysis of the JCOG trial: JCOG0502

11 May 2022 5:39 PM | Anonymous

Seiichiro Mitani  1   2 , Ken Kato  3 , Hiroyuki Daiko  4 , Yoshinori Ito  5 , Isao Nozaki  6 , Takashi Kojima  7 , Masahiko Yano  8 , Satoru Nakagawa  9 , Masaki Ueno  10 , Masaya Watanabe  11 , Shigeru Tsunoda  12 , Tetsuya Abe  13 , Shigenori Kadowaki  14 , Tomohiro Kadota  15 , Keita Sasaki  16 , Ryunosuke Machida  17 , Yuko Kitagawa  18

Read Abstract: Second primary malignancies in patients with clinical T1bN0 esophageal squamous cell carcinoma after definitive therapies: supplementary analysis of the JCOG trial: JCOG0502 

Affiliated Societies



International  Interdisciplinary  Everything Esophageal


The International Society for Diseases of the Esophagus is a 501(c)3 non-profit organization. © International Society for Disease of the Esophagus – ISDE 2024 | Any unauthorized use or reproduction of the content is prohibited without explicit permission.

General Inquiries: info@isde.net
Membership Questions: membership@isde.net

Powered by Wild Apricot Membership Software